Marc Rubin

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Diantha Duvall, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Marc Rubin:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CURIS INC Director Non Qualified Stock Option 14.4K $45.1K $3.13 20 May 2025 Direct
TITAN PHARMACEUTICALS INC Executive Chairman, Director Option to Purchase Common Stock 65K 05 Jan 2022 Direct
GALECTIN THERAPEUTICS INC Director Stock Option (right to buy) 60K 23 Jan 2025 Direct

Insider Reports Filed by Marc Rubin

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CRIS CURIS INC 20 May 2025 1 $45.1K 4 Director 22 May 2025, 16:13
CRIS CURIS INC 28 Jan 2025 1 $5.01K 4 Director 30 Jan 2025, 16:06
GALT GALECTIN THERAPEUTICS INC 23 Jan 2025 1 $0 4 Director 27 Jan 2025, 16:07
CRIS CURIS INC 21 May 2024 1 $49.4K 4 Director 23 May 2024, 16:09
GALT GALECTIN THERAPEUTICS INC 24 Jan 2024 1 $0 4 Director 07 Feb 2024, 16:51
GALT GALECTIN THERAPEUTICS INC 26 Jan 2023 1 $0 4 Director 30 Jan 2023, 15:47
CRIS CURIS INC 23 Jan 2023 1 $0 4 Director 24 Jan 2023, 15:14
SHWZ Medicine Man Technologies, Inc. 28 Oct 2022 0 $0 3/A Incorrect Filing 02 Dec 2022, 10:32
CRIS CURIS INC 31 Jan 2022 1 $0 4 Director 31 Jan 2022, 16:33
GALT GALECTIN THERAPEUTICS INC 24 Jan 2022 1 $0 4 Director 25 Jan 2022, 15:35
TTNP TITAN PHARMACEUTICALS INC 05 Jan 2022 1 $0 4 Executive Chairman, Director 05 Jan 2022, 17:48